New injection aims to tame stubborn high blood pressure in kidney patients
NCT ID NCT07483372
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new medicine called SC101, given as a single injection around the kidneys, for people with resistant high blood pressure and moderate to severe chronic kidney disease. The main goal is to check safety, with only 3 participants. Researchers will also monitor blood pressure changes over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGE 3-4) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suzhou Municipal Hospital
RECRUITINGSuzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Plant-Based diet and exercise may boost mobility in kidney patients
- Do herbal remedies harm kidneys? new study investigates
- AI-Powered 1-Minute ECG could spot hidden heart risks
- Can a phosphate diet test improve kidney disease care?
- Kidney disease patients get a boost from a simple booklet
- Could a simple Under-the-Tongue spray protect kidneys?